The Beginning
During his internship at AIIMS Jodhpur, Dr. Maanas Jain witnessed a moment that would change the course of his career. A patient was on the brink of death following multiple failed intubation attempts with a traditional direct laryngoscope. The situation seemed hopeless until a resident rushed in with a videolaryngoscope borrowed from the ICU. With the advantage of an internal view, the patient was intubated immediately, and the patient's life was saved.
This clinical "near-miss" sparked a troubling realization: if an apex tertiary care center like AIIMS faced a scarcity of these life-saving tools, what was happening in smaller district hospitals and rural clinics? Across India, thousands of patients were likely losing their lives simply because the right technology wasn't in the right room at the right time.
The Barrier: Cost vs. Care
The problem was caused buy a massive gap in economics:
-
Direct Laryngoscope: ₹1,000 – ₹2,000
-
Videolaryngoscope: ₹1.5 Lakhs – ₹5 Lakhs
Technically, the primary difference is the integration of a camera. Dr. Jain believed that high costs should never be the barrier between a doctor and a successful intubation.
Challenging the Industry Mindset
As Maanas began developing the solution, he encountered a significant wall—not of technology, but of perspective. Engineers, grant funders, and business advisors all gave the same feedback: "The price is too low. The device is too simple."
The prevailing logic in medical device manufacturing was that to be successful, a product needed a "Unique Selling Proposition" (USP) packed with complex features to justify a high price tag. Many advised him that if competitors were charging lakhs, he should only price his device slightly lower to maximize profit.
But as a doctor, Maanas saw a different reality. Adding unnecessary complexity and cost might satisfy a business model, but it would betray the very doctors and patients he set out to help. High prices would keep the device locked in elite urban hospitals, leaving rural healthcare exactly where it was.
Thus, refusing to compromise on accessibility, Maanas made a defining choice: to move forward without traditional grant funding.
By launching Quintubate Private Limited as a bootstrapped startup, UVEAL maintained the freedom to prioritize impact over margins. We stay committed to the radical idea that a medical device doesn't need to be expensive to be elite—it just needs to work when a life is on the line.
The Vision for UVEAL
The goal became clear: Democratize airway management.
By developing a universal attachment capable of transforming any standard laryngoscope into a high-functioning videolaryngoscope, we could bridge the gap between affordability and advanced technology. UVEAL was born from the belief that every hospital—from urban centers to rural outposts—deserves the clarity of video, ensuring that no life is ever lost for lack of a better view.
